The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo

Wound Repair and Regeneration

Volumn 22, Issue 5, 2014, Pages 622-630

  Ding, Jie ^a   Ma, Zengshuan ^a   Liu, Hongbin ^a   Kwan, Peter ^a   Iwashina, Takashi ^a   Shankowsky, Heather A ^a   Wong, Donald ^b   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b British Canadian BioSciences Corporation   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CTCE 9908; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; CHEMOKINE RECEPTOR CXCR4; CTCE-9908; PEPTIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN FIBER; CONTROLLED STUDY; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; HYPERTROPHIC SCAR; IN VIVO STUDY; MACROPHAGE; MALE; MIDDLE AGED; MONOCYTE; MOUSE; MYOFIBROBLAST; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR FORMATION; SKIN FIBROSIS; SPLIT THICKNESS SKIN GRAFT; ANIMAL; ANTAGONISTS AND INHIBITORS; CICATRIX, HYPERTROPHIC; DERMIS; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; NUDE MOUSE; PATHOLOGY; SKIN TRANSPLANTATION; WOUND HEALING;

ADULT; ANIMALS; CICATRIX, HYPERTROPHIC; DERMIS; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; HUMANS; MALE; MICE, NUDE; MIDDLE AGED; PEPTIDES; RECEPTORS, CXCR4; SKIN TRANSPLANTATION; WOUND HEALING;

EID: 84934297923     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12208     Document Type: Article

References (40)

1. Pilling D, Fan T, Huang D, Kaul B, Gomer RH. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 2009; 4: e7475.
2. Yang L, Scott PG, Giuffre J, Shankowsky HA, Ghahary A, Tredget EE. Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002; 82: 1183–1192.
3. Yang L, Scott PG, Dodd C, Medina A, Jiao H, Shankowsky HA, et al. Identification of fibrocytes in post-burn hypertrophic scar. Wound Repair Regen 2005; 13: 398–404.
4. Wang J, Jiao H, Stewart TL, Lyons MV, Shankowsky HA, Scott PG, et al. Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes. J Leukoc Biol 2007; 82: 1554–1563.
5. Delavary BM, Veer WM, Egmond M, Niessen FB, Beelen RH. Macrophages in skin injury and repair. Immunobiology 2011; 216: 753–762.
6. Grieb G, Steffens G, Pallua N, Bernhagen J, Bucala R. Circulating fibrocytes—biology and mechanisms in wound healing and scar formation. Int Rev Cell Mol Biol 2011; 291: 1–19.
7. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007; 87: 858–870.
8. Mirza R, DiPietro LA, Koh TJ. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am J Pathol 2009; 175: 2454–2462.
9. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996; 184: 110l–119.
10. Hamada T, Möhle R, Hesselgesser J, Hoxie J, Nachman RL, Moore MA, et al. Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med 1998; 188: 539–548.
11. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595–599.
12. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 2004; 4: 540–550.
13. Xu J, Mora A, Shim H, Stecenko A, Brigham KL, Rojas M. Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis. Am J Respir Cell Mol Biol 2007; 37: 291–299.
14. Song JS, Kang CM, Kang HH, Yoon HK, Kim YK, Kim KH, et al. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis. Exp Mol Med 2010; 42: 465–472.
15. Antoniou KM, Papadaki HA, Soufla G, Kastrinaki MC, Damianaki A, Koutala H, et al. Investigation of bone marrow mesenchymal stem cells (BM MSCs) involvement in idiopathic pulmonary fibrosis (IPF). Respir Med 2010; 104: 1535–1542.
16. Ding J, Hori K, Zhang R, Marcoux Y, Honardoust D, Shankowsky HA, et al. Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of post-burn hypertrophic scar (HTS). Wound Repair Regen 2011; 19: 568–578.
17. Tredget EE, Shankowsky HA, Pannu R, Nedelec B, Iwashina T, Ghahary A, et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: effects of interferon alpha-2b. Plast Reconstr Surg 1998; 102: 1317–1328.
18. Telasky C, Tredget EE, Shen Q, Khorramizadeh MR, Iwashina T, Scott PG, et al. IFN-alpha2b suppresses the fibrogenic effects of insulin-like growth factor-1 in dermal fibroblasts. J Interferon Cytokine Res 1998; 18: 571–577.
19. Lee JP, Jalili RB, Tredget EE, Demare JR, Ghahary A. Antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon Cytokine Res 2005; 25: 627–631.
20. Faber A, Roderburg C, Wein F, Saffrich R, Seckinger A, Horsch K, et al. The many facets of SDF-1alpha, CXCR4 agonists and antagonists on hematopoietic progenitor cells. J Biomed Biotechnol 2007; 3: 26065–26074. (10 pages).
21. Kim SY, Lee CH, Midura BV, Yeung C, Mendoza A, Hong SH, et al. Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin Exp Metastasis 2008; 25: 201–211.
22. Richert MM, Vaidya KS, Mills CN, Richert MM, Vaidya KS, Mills CN, et al. Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone. Oncol Rep 2009; 21: 761–767.
23. Kwong J, Kulbe H, Wong D, Chakravarty P, Balkwill F. An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells. Mol Cancer Ther 2009; 8: 1893–1905.
24. Hassan S, Buchanan M, Jahan K, Aguilar-Mahecha A, Gaboury L, Muller WJ, et al. CXCR4 peptide antagonist inhibits primary breast tumor growth, metastasis and enhances the efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse model. Int J Cancer 2011; 129: 225–232.
25. Wang J, Ding J, Jiao H, Honardoust D, Momtazi M, Shankowsky HA, et al. Human hypertrophic scar-like nude mouse model: characterization of the molecular and cellular biology of the scar process. Wound Repair Regen 2011; 19: 274–285.
26. Momtazi M, Kwan P, Ding J, Anderson CC, Honardoust D, Goekjian S, et al. A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar. Wound Repair Regen 2013; 21: 77–87.
27. Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 2014; 71(4): 549–574.
28. Frangogiannis NG, Dewald O, Xia Y, Ren G, Haudek S, Leucker T, et al. Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation 2007; 115: 584–592.
29. Liaskou E, Zimmermann HW, Li KK, Oo YH, Suresh S, Stamataki Z, et al. Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics. Hepatology 2013; 57: 385–398.
30. Zimmermann HW, Seidler S, Gassler N, Nattermann J, Luedde T, Trautwein C, et al. Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis. PLoS ONE 2011; 6: e21381.
31. Sarrazy V, Billet F, Micallef L, Coulomb B, Desmoulière A. Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen 2011; 19 (S1): s10–15.
32. Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012; 18: 1028–1040.
33. Jang HS, Kim JI, Jung KJ, Kim J, Han KH, Park KM. Bone marrow-derived cells play a major role in kidney fibrosis via proliferation and differentiation in the infiltrated site. Biochim Biophys Acta 2013; 1832: 817–825.
34. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 171: 380–389.
35. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C, et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005; 166: 675–684.
36. Yannas IV. Tissue and organ regeneration in adults. New York: Springer, 2001: 219–243.
37. Kwan P, Hori K, Ding J, Tredget EE. Scar and contracture: biological principles. Hand Clin 2009; 25: 511–528.
38. Tredget EE, Ding J. Wound healing: from embryos to adults and back again. Lancet 2009; 373: 1226–1228.
39. Wang J, Jiao H, Stewart TL, Shankowsky HA, Scott PG, Tredget EE. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring. Wound Repair Regen 2007; 15: 530–539.
40. Hori K, Ding J, Marcoux Y, Iwashina T, Sakurai H, Tredget EE. Impaired cutaneous wound healing in transforming growth factor-β inducible early gene1 knockout mice. Wound Repair Regen 2012; 20: 166–177.